Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Female participants of any ethnic background.
- Adolescents aged 14 to 18 years old.
- Those who can provide written agreement to participate, along with agreement from a parent or guardian for participants under 18.
- People whose first language is English, or who are fluent in English.
- People who are right-handed.
- People who own a personal mobile phone (used for a type of regular survey during the study).
- People who are in a specific part of their menstrual cycle (the follicular phase) at the time of the brain scan session.
For the depression group specifically, people who:
- Have been diagnosed with Major Depressive Disorder (MDD) according to a standard medical assessment.
- Have not taken any psychiatric medications for a set period of time before joining — the length of time varies depending on the medication (confirm with trial site for details on specific medications).
For the healthy comparison group specifically, people who:
- Have no current or past diagnosis of any psychiatric condition or substance use disorder.
- Have no close family members (parents, siblings, or children) with a history of depression, bipolar disorder, or psychosis.
Who may not be able to join:
- People with a history of a head injury that caused loss of consciousness.
- People with a history of seizures or a seizure disorder.
- People with a serious or unstable physical health condition affecting the heart, liver, kidneys, lungs, hormonal system, nervous system, or blood.
- People with a history of using cocaine, amphetamines, methamphetamine, or similar stimulant drugs.
- People with a history of using dopamine-affecting drugs, including methylphenidate (a medication used for ADHD).
- People currently using hormone replacement therapy, anabolic steroids, or hormonal contraception (such as the pill).
- People with clinical or test-confirmed signs of an underactive thyroid.
- People with a physical or neurological condition that could affect the results of a brain scan measuring blood flow.
- People who cannot safely undergo an MRI scan — for example, due to claustrophobia, a pacemaker, surgically implanted metal devices, cochlear implants, metal braces, or other metal in the body.
- People who are currently pregnant.
- People who test positive for certain substances on a drug test taken on the day of the scan (including stimulants, marijuana, benzodiazepines, opiates, and several others).
- People who have previously had electroconvulsive therapy (ECT).
- People for whom the study clinician considers participation to be unsafe due to thoughts of suicide.
For the depression group specifically:
- People whose depression diagnosis is considered to be caused by another condition, rather than being the primary diagnosis (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emily L Belleau, PhD, Mclean Hospital
Phone: 6178554245
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Blood-Oxygen-Level-Dependent Imaging (BOLD) activation of the ventral striatum and ventral medial prefrontal cortex
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.